Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This is a therapeutic trial study to demonstrate whether Goserelin, a LHRH agonist has
benefit in SBMA
Objective:
1. To study effects of Goserelin to clinical course of patients with spinal and bulbar
muscular atrophy in Thailand
2. To demonstrate physiological and pathological changes in treated patients with
Goserelin.
3. To assess tolerability and adverse effect of Goserelin therapy